Apis Partners to invest in L&T IFD, aims for a 25% stake worth $110M
Category: #headlines  By Pankaj Singh  Date: 2019-04-27
  • share
  • Twitter
  • Facebook
  • LinkedIn

Apis Partners to invest in L&T IFD, aims for a 25% stake worth $110M

Apis Partners has signed a binding agreement for the acquisition of the stake and will be investing through one of its funds called Apis Growth Fund II.

UK-based venture capital firm Apis Partners has reportedly announced plans to acquire a 25 per cent stake in L&T Financial Holdings arm L&T IDF (Infra Debt Fund), for US$110 million.

Apparently, the proposed investment is aimed at supporting the growth of the loan book of L&T IDF across various sectors including renewable energy, airports, power transmission, roads and ports. In addition, the funding is likely to consolidate IDF’s technology, capital structure and digitization strategy. For those uninitiated, L&T IDF holds a loan book worth Rs. 8,000 crore.

Authentic sources reported that about 70% of the investment is growth capital for L&T IDF, while 30% would be deployed for a secondary transaction in which shareholders will exit their holdings. Sources further claimed that the partnership with Apis is anticipated to help IDF with gaining access to low-cost international fund sources that will be deployed for refinancing operational infrastructure projects in India.

L&T IDF’s Chief Executive Shiva Rajaraman stated that the Indian infrastructure market provides significant growth prospects for specialized re-financiers such as L&T IDF. He added that the company’s IDF platform will be in a better position to utilize these opportunities through the partnership with Apis Partners and remain a leader in key areas of the infrastructure refinancing space.

Dinanath Dubhashi, the Chief Executive & Managing Director of LTFH (L&T Finance Holdings), an IDF promoter, was reportedly quoted saying that the latest alliance with Apis reflects the value creation offered by India’s infrastructure financing space to the investors who keep looking for long-term sustainable returns. Apis Partners’ Managing Partner & Co-founder, Udayan Goyal, claimed that IDF holds an exceptional track record for refinancing high-potential infrastructure projects as well as raising funds at competitive rates.

Source Credits: https://www.businesstoday.in/top-story/apis-partners-plans-to-pick-25-stake-for-110-million-in-lt-infra-debt-fund/story/340410.html

https://www.thehindubusinessline.com/markets/lt-idf-to-raise-110-mn-from-apis-partners/article26943088.ece

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Dressbarn confirms 53 stores to close in August as wind down nears
Dressbarn confirms 53 stores to close in August as wind down nears
By Pankaj Singh

Ascena shares have been down by more than 75% this year and are trading at below $1 Ascena Retail Group, an American retailer for women’s clothing, recently announced that it is going to shut down 53 locations of Dressbarn by the end of August...

Japan introduces working group to examine impact of Facebook’s Libra
Japan introduces working group to examine impact of Facebook’s Libra
By Pankaj Singh

Japan is looking to garner greater support due to the wide range of policies which can be affected by digital currencies. Japanese authorities have reportedly established a working group to discuss the impact Libra digital coin proposed by Facebook ...

Ligand Pharma announces positive results from trial of CE-Iohexol
Ligand Pharma announces positive results from trial of CE-Iohexol
By Pankaj Singh

Ligand Pharmaceuticals, a US-based biopharmaceutical company recently announced positive top line results from clinical trial of its internal CE (Captisol-enabled) Iohexol program. The study attained primary endpoint indicating pharmacokinetic b...